Skip to main content
Premium Trial:

Request an Annual Quote

ProteoGenix Human Immune COVID-19 Library

ProteoGenix has launched a Human Immune COVID-19 Library to facilitate the discovery of antibodies against SARS-CoV-2. Created using blood samples from dozens of recovered COVID-19 patients, the library is adapted for screening with phage display and features 1.2 x 1010 different clones. The phage display screening technology coupled with the library's diversity is expected to speed the discovery of antibodies with the strongest affinity, specificity, and viral blocking activity, the company said. ProteoGenix said that it also offers a broad diversity of ready-made SARS-CoV-2 antigens, as well as custom antigen development services. Within eight weeks, clients can receive three to 10 unique and royalty-free antibody sequences with optimal affinity.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.